Cargando…
Panax ginseng: Inflammation, platelet aggregation, thrombus formation, and atherosclerosis crosstalk
Ginseng has been widely studied due to its various therapeutic properties on various diseases such as cardiovascular disease (CVD). Cardiovascular disease has been canonically known to be caused by high levels of low-density lipoproteins (LDL) in the bloodstream, in addition to the impaired vasodila...
Autores principales: | Lee, Yuan Yee, Kim, Sung Dae, Park, Seung-Chun, Rhee, Man Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753522/ https://www.ncbi.nlm.nih.gov/pubmed/35058727 http://dx.doi.org/10.1016/j.jgr.2021.09.003 |
Ejemplares similares
-
COVID-19 and Panax ginseng: Targeting platelet aggregation, thrombosis and the coagulation pathway
por: Lee, Yuan Yee, et al.
Publicado: (2022) -
In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism
por: Quah, Yixian, et al.
Publicado: (2023) -
Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation
por: Jeong, Dahye, et al.
Publicado: (2017) -
Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation
por: Jang, Ja-Young, et al.
Publicado: (2013) -
DK-MGAR101, an extract of adventitious roots of mountain ginseng, improves blood circulation by inhibiting endothelial cell injury, platelet aggregation, and thrombus formation
por: Seong, Hye Rim, et al.
Publicado: (2022)